Alnylam Pharmaceuticals | ALNY - 股票

金融业

USD

USD 5.13B

现金及等价物

USD 1.71B

USD 211.12M

USD 4.22B

USD 1.35B

USD 1.28B

USD 137.59M

USD 145.22M

2.23K

EPS每股收益

USD 1.99

股本和储备

USD 1.08B

USD 825.01M

债务利息支出

USD 69.29M

USD 26.63M

USD 2.48B

USD 38.41B

USD 205.99M

USD 898.54M

USD 137.59M

普通股股本

USD 133.44M

80.04

USD 221.65M

USD 1.17B

销售和管理费用

USD 282.51M

USD 200.15M

贸易债权人

USD 126.63M

应收帐款人

USD 883.96M

	股票	更改		日
Acadia Pharmaceuticals	USD 31.57M		3.1M	2026-03
Agios Pharmaceuticals	USD 35.09M		2.17M	2026-03
Alnylam Pharmaceuticals	USD 200.15M		117.43M	2026-03
Amgen	USD 6.19B		39M	2026-03
Arrowhead Research	USD -173.08M		173.08M	2024-12
BioCryst Pharmaceuticals	USD 5.98M		587K	2026-03
BioMarin Pharmaceutical	USD 1.27B		25.66M	2026-03
Incyte	USD 115.62M		14.56M	2026-03
Ionis Pharmaceuticals	USD 5.56M		4.49M	2026-03
Moderna	USD 146M		7M	2026-03
Neurocrine Biosciences	USD 64.5M		4.5M	2026-03
Novartis	USD 6.42B		114M	2025-09
PTC Therapeutics	USD 75.57M		4.08M	2026-03
Regeneron Pharmaceuticals	USD 3.1B		97.2M	2026-03
Sanofi	EUR 22.69B		1.81B	2025-12
Sarepta Therapeutics	USD 1B		86.37M	2026-03
Takeda	JPY 1.41T		107.71B	2025-12
Ultragenyx Pharmaceutical	USD 55M		3M	2026-03
Vertex Pharmaceuticals	USD 1.77B		79.9M	2026-03